Get the latest news, insights, and market updates on BLFS (BioLife Solutions, Inc.). Explore the news page 5 on MyTopStock.com for investor discussions, analysis, and real-time stock performance coverage.
Why BioLife Solutions (BLFS) Is Up After Raising 2025 Guidance and Sharpening Its Cell Processing Focus
BioLife Solutions reported third-quarter 2025 results, with revenue of US$28.07 million and net income of US$621,000, also updating its full-year guidance upward after completing the sale of its evo cold chain logistics division in October. A standout detail is the 33% year-over-year cell processing revenue growth, as the company sharpens its focus on this core segment and recurring high-value streams post-divestiture. We'll examine how BioLife Solutions' raised 2025 guidance and narrow... Nov 9, 2025 - $BLFS
BioLife Solutions Reports Third Quarter 2025 Financial Results
BioLife Solutions, Inc. (Nasdaq: BLFS) ("BioLife" or the "Company"), a leading developer and supplier of cell processing tools and services for the cell and gene therapy ("CGT") market, announces financial results for the three and nine months ended September 30, 2025. Nov 6, 2025 - $BLFS
BioLife Solutions to Report Third Quarter 2025 Financial Results and Business Update on November 6, 2025
BioLife Solutions, Inc. (NASDAQ: BLFS), a leading developer and supplier of bioproduction products and services for the cell and gene therapy ("CGT") market, today announced the Company's third quarter 2025 financial results will be released after market close on Thursday, November 6, 2025. The Company will host a conference call and live webcast at 4:30pm ET (1:30pm PT) that day. Management will provide an overview of the Company's financial results and give a general business update. Oct 23, 2025 - $BLFS
A Fresh Look at BioLife Solutions (BLFS) Valuation Following Recent Share Price Gains
BioLife Solutions (BLFS) shares have delivered strong gains over the past 3 months, rising 20%. The company’s revenue increased by 18% last year, while net income growth climbed by an impressive 65%. See our latest analysis for BioLife Solutions. BioLife Solutions’ share price momentum has picked up notably, with a 20.3% return over the last quarter and a total shareholder return of 16.8% for the past year. The stock’s recent gains suggest renewed optimism around its growth outlook, following... Oct 9, 2025 - $BLFS
Peli BioThermal expands cold chain capabilities with EVO acquisition
As the cold chain becomes a critical link in the life sciences supply chain, Peli BioThermal is expanding its reach. The company announced the acquisition of Evo Cold Chain from BioLife Solutions, a move designed to strengthen its position in cryogenic transport and support the fast-growing cell and gene therapy (CGT) logistics market. The acquisition […] The post Peli BioThermal expands cold chain capabilities with EVO acquisition appeared first on FreightWaves. Oct 8, 2025 - $BLFS
Global Biopreservation Market Set to Surpass USD 7.1 Billion by 2029 | MarketsandMarkets™
Advancements in healthcare expenditure, research investment, and regenerative medicine are fueling growth while storage logistics remain a critical challengeDelray Beach, FL,, Oct. 08, 2025 (GLOBE NEWSWIRE) -- formation, and contamination risks threaten sample viability. Ensuring consistent global transportation standards will be a key differentiator for market leaders, particularly as demand for international collaboration and sample sharing increases. Request Sample Pages : https://www.markets Oct 8, 2025 - $BLFS
We use cookies and similar technologies to collect and process data such as browsing activity or unique identifiers.
Selecting "Allow All" to help us understand site usage and improve the platform.
Choosing "Essential Cookies Only" enables only the cookies necessary for core site functions, such as staying logged in.
For more information, please see our Privacy Policy.
Continue with Google
Continue with Facebook
Continue with Microsoft
Continue with Apple